{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T06:12:45Z","timestamp":1777356765567,"version":"3.51.4"},"reference-count":25,"publisher":"Japanese Society of Allergology","issue":"4","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,29]],"date-time":"2015-04-29T00:00:00Z","timestamp":1430265600000},"content-version":"vor","delay-in-days":1214,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Allergology International"],"published-print":{"date-parts":[[2012]]},"DOI":"10.2332\/allergolint.12-rai-0497","type":"journal-article","created":{"date-parts":[[2012,12,11]],"date-time":"2012-12-11T17:34:51Z","timestamp":1355247291000},"page":"517-527","source":"Crossref","is-referenced-by-count":41,"title":["Japanese Guidelines for Diagnosis and Treatment of Urticaria in Comparison with Other Countries"],"prefix":"10.2332","volume":"61","author":[{"given":"Michihiro","family":"Hide","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaaki","family":"Hiragun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1154","reference":[{"key":"10.2332\/allergolint.12-RAI-0497_bb0005","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1398-9995.2005.00964.x","article-title":"EAACI\/GA2LEN\/EDF guideline: definition, classification and diagnosis of urticaria","volume":"61","author":"Zuberbier","year":"2006","journal-title":"Allergy"},{"key":"10.2332\/allergolint.12-RAI-0497_bb0010","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1398-9995.2005.00962.x","article-title":"EAACI\/GA2LEN\/EDF guideline: management of urticaria","volume":"61","author":"Zuberbier","year":"2006","journal-title":"Allergy"},{"key":"10.2332\/allergolint.12-RAI-0497_bb0015","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/j.1398-9995.2009.02179.x","article-title":"EAACI\/GA2LEN\/EDF\/WAO guideline: definition, classification and diagnosis of urticaria","volume":"64","author":"Zuberbier","year":"2009","journal-title":"Allergy"},{"key":"10.2332\/allergolint.12-RAI-0497_bb0020","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1111\/j.1398-9995.2009.02178.x","article-title":"EAACI\/GA2LEN\/EDF\/WAO guideline: Management of urticaria","volume":"64","author":"Zuberbier","year":"2009","journal-title":"Allergy"},{"issue":"115","key":"10.2332\/allergolint.12-RAI-0497_bb0025","first-page":"703","article-title":"Guidelines for the diagnosis and treatment of urticaria and angioedema","author":"Hide","year":"2005","journal-title":"Nihon Hifukagakkai Zasshi [Jpn J Dermatol]"},{"key":"10.2332\/allergolint.12-RAI-0497_bb0030","series-title":"Primary care version of guidelines for the diagnosis and treatment of urticaria and angioedema","author":"Hide","year":"2007"},{"key":"10.2332\/allergolint.12-RAI-0497_bb0035","series-title":"Japanese Guideline for the Diagnosis and Treatment of Allergic Diseases 2010","first-page":"317","article-title":"Urticaria and angioedema","author":"Hide","year":"2010"},{"key":"10.2332\/allergolint.12-RAI-0497_bb0040","first-page":"1339","article-title":"JDA guidelines. Guidelines for the diagnosis and treatment of urticaria","volume":"121","author":"Hide","year":"2011","journal-title":"Nihon Hifukagakkai Zasshi [Jpn J Dermatol]"},{"key":"10.2332\/allergolint.12-RAI-0497_bb0045","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1398-9995.1997.tb02593.x","article-title":"Physical urticaria: classification and diagnostic guidelines. An EAACI position paper","volume":"52","author":"Kontou-Fili","year":"1997","journal-title":"Allergy"},{"key":"10.2332\/allergolint.12-RAI-0497_bb0050","first-page":"521","article-title":"The diagnosis and management of urticaria: a practice parameter part I: acute urticaria\/angioedema part II: chronic urticaria\/angioedema. Joint Task Force on Practice Parameters","volume":"85","author":"Joint Task Force on Practice Parameters","year":"2000","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.2332\/allergolint.12-RAI-0497_bb0055","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1046\/j.1365-2133.2001.04175.x","article-title":"Humphreys F; British Association of Dermatologists. Management and diagnostic guidelines for urticaria and angio-oedema","volume":"144","author":"Grattan","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.2332\/allergolint.12-RAI-0497_bb0060","first-page":"225","article-title":"Asero R; AAITO Committee for Chronic Urticaria and Pruritus Guidelines. AAITO Position paper. Chronic urticaria: diagnostic workup and treatment","volume":"39","author":"Tedeschi","year":"2007","journal-title":"Eur Ann Allergy Clin Immunol"},{"key":"10.2332\/allergolint.12-RAI-0497_bb0065","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1365-2222.2007.02678.x","article-title":"BSACI guidelines for the management of chronic urticaria and angiooedema","volume":"37","author":"Powell","year":"2007","journal-title":"Clin Exp Allergy"},{"key":"10.2332\/allergolint.12-RAI-0497_bb0070","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/j.1365-2133.2007.08283.x","article-title":"Humphreys F; British Association of Dermatologists Therapy Guidelines and Audit Subcommittee. Guidelines for evaluation and management of urticaria in adults and children","volume":"157","author":"Grattan","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.2332\/allergolint.12-RAI-0497_bb0075","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1398-9995.2010.02496.x","article-title":"Unmet clinical needs in chronic spontaneous urticaria. A GA2LEN task force report","volume":"66","author":"Maurer","year":"2011","journal-title":"Allergy"},{"key":"10.2332\/allergolint.12-RAI-0497_bb0080","series-title":"Allgol Int","article-title":"Guideline for hereditary angioedema (HAE) 2010 by the Japanese Association for Complement Research","author":"Horiuchi","year":"2012"},{"key":"10.2332\/allergolint.12-RAI-0497_bb0085","series-title":"Br J Dermatol Epub","article-title":"Chronic Idiopathic Urticaria (CIU) is no longer idiopathic: time for an update!","author":"Maurer","year":"2012"},{"key":"10.2332\/allergolint.12-RAI-0497_bb0090","series-title":"The Urticarias","first-page":"135","article-title":"Urticaria\u2014clinical aspects","author":"Champion","year":"1985"},{"key":"10.2332\/allergolint.12-RAI-0497_bb0095","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1365-2222.2007.02716.x","article-title":"Towards rationalizing the nomenclature and classification of urticaria: some guidance on guidelines","volume":"37","author":"Grattan","year":"2007","journal-title":"Clin Exp Allergy"},{"key":"10.2332\/allergolint.12-RAI-0497_bb0100","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jaci.2008.07.006","article-title":"Treatment of chronic autoimmune urticaria with omalizumab","volume":"122","author":"Kaplan","year":"2008","journal-title":"J Allergy Clin Immnol"},{"key":"10.2332\/allergolint.12-RAI-0497_bb0105","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s11882-012-0268-1","article-title":"Biologic agents in the treatment of urticaria","volume":"12","author":"Kaplan","year":"2012","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.2332\/allergolint.12-RAI-0497_bb0110","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000320233","article-title":"Anti-immunoglobulin E treatment of patients with recalcitrant physical urticaria","volume":"154","author":"Metz","year":"2011","journal-title":"Int Arch Allergy Immunol"},{"key":"10.2332\/allergolint.12-RAI-0497_bb0115","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1398-9995.2007.01591.x","article-title":"Successful treatment of cholinergic urticaria with anti-immunoglobulin E therapy","volume":"63","author":"Metz","year":"2008","journal-title":"Allergy"},{"key":"10.2332\/allergolint.12-RAI-0497_bb0120","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2500\/aap.2009.30.3237","article-title":"A case of severe refractory chronic urticaria: a novel method for evaluation and treatment","volume":"30","author":"Otto","year":"2009","journal-title":"Allergy Asthma Proc"},{"key":"10.2332\/allergolint.12-RAI-0497_bb0125","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jaci.2011.06.010","article-title":"A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria","volume":"128","author":"Saini","year":"2011","journal-title":"J Allergy Clin Immunol"}],"container-title":["Allergology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1323893015302525?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1323893015302525?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T23:59:17Z","timestamp":1498003157000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1323893015302525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012]]}},"alternative-id":["S1323893015302525"],"URL":"https:\/\/doi.org\/10.2332\/allergolint.12-rai-0497","relation":{},"ISSN":["1323-8930"],"issn-type":[{"value":"1323-8930","type":"print"}],"subject":[],"published":{"date-parts":[[2012]]}}}